View:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 AND 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the Month of June 2014
File No. 000-54598
Stellar Biotechnologies Inc.
(Name of Registrant)
332 E. Scott Street, Port Hueneme, CA 93041
(Address of Principal executive offices)
Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
SIGNATURE
Pursuant to the requirements of the securities Exchange Act of 1934, the registrant has duly caused this Form 6-K to be signed on its behalf by the undersigned, thereunto duly authorized.
Stellar Biotechnologies, Inc.
(Registrant)
Dated: 6/9/14 By: /s/ Kathi Niffenegger
Kathi Niffenegger
Chief Financial Officer
Exhibits:
99.1 Notice of Change of Auditor Dated June 3, 2014
99.2 Change of Auditor Acknowledgement D&H Group LLP Dated June 4, 2014
99.3 Change of Auditor Acknowledgement Moss Adams LLP Dated June 3, 2014
Exhibit 99.1
STELLAR BIOTECHNOLOGIES, INC.
332 E. Scott Street
Port Hueneme, California 93041
(the “Company”)
NOTICE OF CHANGE OF AUDITOR
TO: D&H GROUP LLP, CHARTERED ACCOUNTANTS
AND TO: MOSS ADAMS LLP, CERTIFIED PUBLIC ACCOUNTANTS
NOTICE IS HEREBY GIVEN that, on the advice of the Audit Committee of the Company, the Board of Directors of the Company resolved on June 3, 2014 that:
(a) The resignation of D&H Group LLP, Chartered Accountants, on June 3, 2014, as auditor of the Company be accepted, and
(b) Moss Adams LLP, Certified Public Accountants, be appointed as auditor of the Company to be effective June 3, 2014, to hold office until the next annual meeting at a remuneration to be fixed by the directors.
In accordance with National Instrument 51-102 (“NI 51-102”) we confirm that:
(a) D&H Group LLP, Chartered Accountants, resigned on its own initiative as auditor of the Company;
(b) D&H Group LLP, Chartered Accountants, has not expressed any reservation in its reports for the two most recently completed fiscal years of the Company, nor for the period from the most recently completed period for which D&H Group LLP, Chartered Accountants, issued an audit report in respect of the Company and the date of this Notice;
(c) the resignation of D&H Group LLP, Chartered Accountants, and appointment of Moss Adams LLP, Certified Public Accountants, as auditor of the Company were considered by the Audit Committee and approved by the Board of Directors of the Company;
(d) in the opinion of the Board of Directors of the Company, no “reportable event” as defined in NI 51-102 has occurred in connection with the audits of the two most recently completed fiscal years of the Company, nor any period from the most recently completed period for which D&H Group LLP, Chartered Accountants, issued an audit report in respect of the Company and the date of this Notice; and
(e) the Notice, resignation and letters of the auditors have been reviewed by the Audit Committee and the Board of Directors.
Dated as of June 3, 2014.
STELLAR BIOTECHNOLOGIES, INC.
Per: /s/ Kathi Niffenegger
Kathi Niffenegger
Chief Financial Officer
Exhibit 99.2
June 4, 2014
British Columbia Securities Commission
P.O. Box 10142, Pacific Centre
701 West Georgia Street
Vancouver, B.C. V7Y 1L2
Alberta Securities Commission
Suite 600, 250–5th St. SW
Calgary, Alberta, T2P 0R4
Dear Sirs:
Change of Auditor of Stellar Biotechnologies, Inc. (the “Company”)
We acknowledge receipt of a Notice of Change of Auditor (the “Notice”) dated June 3, 2014 given by the Company to ourselves and Moss Adams LLP, Certified Public Accountants.
Based on our knowledge of the information as of this date, we agree with the statements set out in the Notice.
Yours truly,
D&H GROUP LLP
By: /s/ D&H Group LLP
Exhibit 99.3
June 3, 2014
British Columbia Securities Commission
P.O. Box 10142, Pacific Centre
701 West Georgia Street
Vancouver, B.C. V7Y 1L2
Alberta Securities Commission
Suite 600, 250–5th St. SW
Calgary, Alberta, T2P 0R4
Dear Sirs:
Change of Auditor of Stellar Biotechnologies, Inc. (the “Company”)
We acknowledge receipt of a Notice of Change of Auditor (the “Notice”) dated June 3, 2014 given by the Company to ourselves and D&H Group LLP, Chartered Accountants.
Based on our knowledge of the information as of this date, we agree with the statements set out in the Notice.
Yours truly,
Moss Adams LLP
By: /s/ Moss Adams LLP